Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Mahmood Nadir, Autre. Director active across 1 company, notably Nkarta, Inc.. Cumulatively, 13 filings have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €79k. Activity tracked since 10 May 2021. The latest transaction was filed on 15 January 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Mahmood Nadir
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
5,649 shares@ US$2.075.5% of flowCommon StockSEC:0001193125-26-016862:0
80,000 shares0Common StockSEC:0001193125-26-007897:0
62,000 shares0Common StockSEC:0000950170-25-002831:0
526 shares@ US$4.850.9% of flowCommon StockSEC:0001209191-23-039054:0
37,500 shares0Common StockSEC:0001209191-23-003854:0
7,500 shares@ US$3.8911.2% of flowCommon StockSEC:0000899243-22-028981:0
7,500 shares@ US$3.8911.1% of flowCommon StockSEC:0000899243-22-028290:0
7,500 shares@ US$3.8911.1% of flowCommon StockSEC:0000899243-22-026767:0
6,000 shares0Common StockSEC:0001209191-22-038530:0
12,800 shares0Common StockSEC:0001209191-22-003758:0
3,500 shares@ US$3.896.3% of flowCommon StockSEC:0000899243-21-027552:0
1,800 shares@ US$3.893.2% of flowCommon StockSEC:0000899243-21-024468:0
3,000 shares@ US$27.1636.7% of flowCommon StockSEC:0000899243-21-019206:0
About Mahmood Nadir
Nadir Mahmood is a professional at Nkarta, Inc. His specific role is not detailed, but he contributes to the company's activities. Nadir plays a role in advancing Nkarta's objectives in the biopharmaceutical sector.